a Immunopathology and Cancer Biomarkers , IRCCS CRO National Cancer Institute , Aviano , Italy.
b Department of Medical Oncology , IRCCS CRO National Cancer Institute , Aviano , Italy.
Cancer Biol Ther. 2018 Apr 3;19(4):254-259. doi: 10.1080/15384047.2017.1394540. Epub 2017 Nov 13.
Germline mutations in CDH1, the gene coding for the E-cadherin adhesion protein, are known to cause hereditary diffuse gastric cancer. We identified a new truncating germline mutation (p.Asp538Thrfs*19) in exon 11 of the CDH1 gene in a 41-year-old male with a diffuse gastric cancer. Although he had no parental history of gastric cancer, the co-segregation study in the family detected the same mutation in his healthy 31-year-old brother. The mutation affects one of the extracellular repeat (CAD repeats) domains which is essential for the homophilic binding specificity that directs "E-cadherin" to bind with itself each others. In this case, immunohistochemical analysis showed no expression of E-cadherin in the tumor sample and was a useful prescreening tool to genetic testing. This finding was associated with a poor response to trastuzumab-based treatment.
CDH1 基因编码 E-钙黏蛋白黏附蛋白,其种系突变已知可导致遗传性弥漫性胃癌。我们在一名 41 岁男性弥漫性胃癌患者中鉴定出 CDH1 基因 11 号外显子的一个新的截断种系突变(p.Asp538Thrfs*19)。尽管他没有胃癌的家族史,但家族中的共分离研究在其健康的 31 岁弟弟中检测到了相同的突变。该突变影响一个细胞外重复(CAD 重复)结构域,该结构域对于同种结合特异性至关重要,同种结合特异性指导“E-钙黏蛋白”彼此结合。在这种情况下,免疫组织化学分析显示肿瘤样本中没有 E-钙黏蛋白的表达,这是基因检测的有用预筛选工具。这一发现与曲妥珠单抗治疗反应不良有关。